GSK plc
GSK
$38.56
$0.1550.40%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 285.78% | 802.46% | -105.10% | 11.56% | 205.08% |
| Total Depreciation and Amortization | 302.68% | -79.20% | 53.52% | 15.79% | 33.44% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -95.14% | 584.01% | -10.27% | -1,150.18% | -106.08% |
| Change in Net Operating Assets | -187.44% | -128.33% | 633.08% | 47.23% | -136.05% |
| Cash from Operations | -51.65% | 6.41% | 99.64% | 15.58% | -69.40% |
| Capital Expenditure | 62.40% | -75.53% | -4.18% | -21.15% | 47.91% |
| Sale of Property, Plant, and Equipment | -98.39% | 5,903.24% | -48.42% | 98.97% | -85.42% |
| Cash Acquisitions | -1,114.95% | -1,499.22% | 87.50% | 95.45% | -36,752.70% |
| Divestitures | 80.33% | -64.02% | 55.79% | -132.13% | 56.25% |
| Other Investing Activities | 76.89% | -32.62% | -139.03% | 34.18% | 11.13% |
| Cash from Investing | -0.54% | -50.65% | -197.93% | 614.11% | -156.76% |
| Total Debt Issued | 54.88% | -- | -- | -- | -- |
| Total Debt Repaid | 81.27% | -90.89% | -1.34% | -56.84% | 73.05% |
| Issuance of Common Stock | -- | -100.00% | 0.00% | -94.44% | 1,700.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 1.65% | 1.59% | 3.17% | -14.20% | -2.08% |
| Other Financing Activities | 62.68% | -1,572.00% | 92.58% | -159.23% | 36.89% |
| Cash from Financing | 200.21% | 33.17% | 19.25% | -48.66% | 69.88% |
| Foreign Exchange rate Adjustments | -254.54% | 120.26% | -338.41% | 58.11% | 42.95% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 122.39% | 147.68% | -47.18% | 207.22% | -70.14% |